Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.21.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Summary of Shareholders Equity Warrants Outstanding

 

    Shares  
Outstanding at December 31, 2019     5,397  
Issued     -  
Exercised     (2,576 )
Tendered     -  
Expired     (1,493 )
Outstanding at December 31, 2020     1,328 *
Issued     -  
Exercised     (2 )**
Tendered     -  
Expired     -  
Outstanding at March 31, 2021     1,326 ***

 

* Weighted average exercise price for outstanding warrants is $0.55.
** Converted into approximately 1 thousand shares of commons stock.
*** Weighted average exercise price for outstanding warrants is $0.54.

 

Basic and diluted net loss per common share

 

During the three months ended March 31, 2021 and 2020, diluted earnings per common share is the same as basic earnings per common share because, as the Company incurred a net loss during each period presented, the potentially dilutive securities from the assumed exercise of all outstanding stock options, warrants and conversion of preferred stock, would have an anti-dilutive effect. The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common shareholders because including them would have been anti-dilutive as of March 31, 2021 and 2020:

 

    As of March 31,  
    2021     2020  
Stock options     22,890       20,562  
Preferred Stock and accrued dividend upon conversion     10,123       9,104  
Warrants     1,326       3,371  
Total     34,339       33,037